{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:06:50Z","timestamp":1777860410372,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00296-022-05119-y","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T05:02:52Z","timestamp":1649048572000},"page":"973-987","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Safety of SARS-CoV-2 vaccination in patients with Behcet\u2019s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-8138","authenticated-orcid":false,"given":"Ayse","family":"Ozdede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-8374","authenticated-orcid":false,"given":"Sabriye","family":"Guner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4774-9284","authenticated-orcid":false,"given":"Guzin","family":"Ozcifci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-0340","authenticated-orcid":false,"given":"Berna","family":"Yurttas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0762-7725","authenticated-orcid":false,"given":"Zeynep","family":"Toker Dincer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2959-0978","authenticated-orcid":false,"given":"Zeynep","family":"Atli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2866-4004","authenticated-orcid":false,"given":"U\u011fur","family":"Uyguno\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1468-0153","authenticated-orcid":false,"given":"Eser","family":"Durmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3469-7307","authenticated-orcid":false,"given":"Didar","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-2282","authenticated-orcid":false,"given":"Serdal","family":"U\u011furlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2802-7227","authenticated-orcid":false,"given":"Sabahattin","family":"Saip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-2825","authenticated-orcid":false,"given":"Fehmi","family":"Tabak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6625-1652","authenticated-orcid":false,"given":"Vedat","family":"Hamuryudan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4965-2918","authenticated-orcid":false,"given":"Emire","family":"Seyahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"key":"5119_CR1","unstructured":"https:\/\/covid19.who.int Accessed 8 Mar 2022"},{"key":"5119_CR2","unstructured":"https:\/\/covid19.who.int\/region\/euro\/country\/tr Accessed 8 Mar 2022"},{"issue":"11","key":"5119_CR3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1136\/thoraxjnl-2020-215314","volume":"75","author":"PM George","year":"2020","unstructured":"George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I, Gibbons MA, Hart N, Jenkins RG, McAuley DF, Patel BV, Thwaite E, Spencer LG (2020) Respiratory follow-up of patients with COVID-19 pneumonia. Thorax 75(11):1009\u20131016. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-215314 (PMID:32839287; PMCID:PMC7447111)","journal-title":"Thorax"},{"key":"5119_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","volume":"78","author":"M Nicola","year":"2020","unstructured":"Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R (2020) The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg 78:185\u2013193. https:\/\/doi.org\/10.1016\/j.ijsu.2020.04.018 (PMID:32305533; PMCID:PMC7162753)","journal-title":"Int J Surg"},{"issue":"892","key":"5119_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173751","volume":"5","author":"K Rawat","year":"2021","unstructured":"Rawat K, Kumari P, Saha L (2021) COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies. Eur J Pharmacol 5(892):173751. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173751 (PMID:33245898; PMCID:PMC7685956)","journal-title":"Eur J Pharmacol"},{"issue":"27","key":"5119_CR6","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P\u00e9rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T\u00fcreci \u00d6, Nell H, Schaefer A, \u00dcnal S, Tresnan DB, Mather S, Dormitzer PR, \u015eahin U, Jansen KU, Gruber WC, C4591001 Clinical Trial Group (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 383(27):2603\u20132615. https:\/\/doi.org\/10.1056\/NEJMoa2034577 (Epub 2020 Dec 10, PMID: 33301246; PMCID: PMC7745181)","journal-title":"N Engl J Med"},{"issue":"10","key":"5119_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2107715","volume":"385","author":"A Jara","year":"2021","unstructured":"Jara A, Undurraga EA, Gonz\u00e1lez C, Paredes F, Fontecilla T, Jara G, Pizarro A, Acevedo J, Leo K, Leon F, Sans C, Leighton P, Su\u00e1rez P, Garc\u00eda-Escorza H, Araos R (2021) Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med 385(10):875\u2013884. https:\/\/doi.org\/10.1056\/NEJMoa2107715 (PMID:34233097; PMCID:PMC8279092)","journal-title":"N Engl J Med"},{"issue":"5","key":"5119_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T, COVE Study Group (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384(5):403\u2013416. https:\/\/doi.org\/10.1056\/NEJMoa2035389 (PMID: 33378609; PMCID: PMC7787219)","journal-title":"N Engl J Med"},{"issue":"10296","key":"5119_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","volume":"398","author":"MD Tanriover","year":"2021","unstructured":"Tanriover MD, Do\u011fanay HL, Akova M, G\u00fcner HR, Azap A, Akhan S, K\u00f6se \u015e, Erdin\u00e7 F\u015e, Akal\u0131n EH, Tabak \u00d6F, Pulluk\u00e7u H, Batum \u00d6, \u015eim\u015fek Yavuz S, Turhan \u00d6, Y\u0131ld\u0131rmak MT, K\u00f6ksal \u0130, Ta\u015fova Y, Korten V, Y\u0131lmaz G, \u00c7elen MK, Alt\u0131n S, \u00c7elik \u0130, Bay\u0131nd\u0131r Y, Karao\u011flan \u0130, Y\u0131lmaz A, \u00d6zkul A, G\u00fcr H, Unal S (2021) Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet 398(10296):213\u2013222. https:\/\/doi.org\/10.1016\/S0140-6736(21)01429-X (PMID: 34246358; PMCID: PMC8266301)","journal-title":"Lancet"},{"issue":"9","key":"5119_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.5588\/ijtld.21.0298","volume":"25","author":"C Brazete","year":"2021","unstructured":"Brazete C, Aguiar A, Furtado I, Duarte R (2021) Thrombotic events and COVID-19 vaccines. Int J Tuberc Lung Dis 25(9):701\u2013707. https:\/\/doi.org\/10.5588\/ijtld.21.0298 (PMID:34802491; PMCID:PMC8412105)","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"5119_CR11","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3390\/vaccines9101186","volume":"9","author":"R Hajjo","year":"2021","unstructured":"Hajjo R, Sabbah DA, Bardaweel SK, Tropsha A (2021) Shedding the light on post-vaccine myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients. Vaccines (Basel) 9(10):1186. https:\/\/doi.org\/10.3390\/vaccines9101186 (PMID:34696294; PMCID:PMC8541143)","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"5119_CR12","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1007\/s10072-021-05523-5","volume":"42","author":"M Trimboli","year":"2021","unstructured":"Trimboli M, Zoleo P, Arabia G, Gambardella A (2021) Guillain-Barr\u00e9 syndrome following BNT162b2 COVID-19 vaccine. Neurol Sci 42(11):4401\u20134402. https:\/\/doi.org\/10.1007\/s10072-021-05523-5 (PMID:34346014; PMCID:PMC8331323)","journal-title":"Neurol Sci"},{"issue":"8","key":"5119_CR13","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00296-021-04910-7","volume":"41","author":"E Seyahi","year":"2021","unstructured":"Seyahi E, Bakhdiyarli G, Oztas M, Kuskucu MA, Tok Y, Sut N, Ozcifci G, Ozcaglayan A, Balkan II, Saltoglu N, Tabak F, Hamuryudan V (2021) Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly. Rheumatol Int 41(8):1429\u20131440. https:\/\/doi.org\/10.1007\/s00296-021-04910-7 (PMID:34109466; PMCID:PMC8188953)","journal-title":"Rheumatol Int"},{"issue":"11","key":"5119_CR14","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1001\/jamaoncol.2021.4381","volume":"7","author":"TA Ollila","year":"2021","unstructured":"Ollila TA, Lu S, Masel R, Zayac A, Paiva K, Rogers RD, Olszewski AJ (2021) Antibody response to COVID-19 vaccination in adults with hematologic malignant disease. JAMA Oncol 7(11):1714\u20131716. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4381 (PMID:34379085; PMCID:PMC8358793)","journal-title":"JAMA Oncol"},{"key":"5119_CR15","unstructured":"https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccines-SAGE_recommendation-immunocompromised-persons Accessed 8 Mar 2022"},{"issue":"6","key":"5119_CR16","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00296-021-04841-3","volume":"41","author":"B Yurttas","year":"2021","unstructured":"Yurttas B, Poyraz BC, Sut N, Ozdede A, Oztas M, U\u011furlu S, Tabak F, Hamuryudan V, Seyahi E (2021) Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey. Rheumatol Int 41(6):1105\u20131114. https:\/\/doi.org\/10.1007\/s00296-021-04841-3 (PMID:33779780; PMCID:PMC8006103)","journal-title":"Rheumatol Int"},{"key":"5119_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221490","author":"PM Machado","year":"2021","unstructured":"Machado PM, Lawson-Tovey S, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Rodrigues A, Raffeiner B, Duarte C, Hachulla E, Veillard E, Strakova E, Burmester GR, Yard\u0131mc\u0131 GK, Gomez-Puerta JA, Zepa J, Kearsley-Fleet L, Trefond L, Cunha M, Mosca M, Cornalba M, Soubrier M, Roux N, Brocq O, Durez P, Conway R, Goulenok T, Bijlsma JW, McInnes IB, Mariette X (2021) Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221490 (Epub ahead of print, PMID: 34972811; PMCID: PMC8720639)","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"5119_CR18","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1038\/s41591-021-01469-5","volume":"27","author":"AC Medeiros-Ribeiro","year":"2021","unstructured":"Medeiros-Ribeiro AC, Aikawa NE, Saad CGS, Yuki EFN, Pedrosa T, Fusco SRG, Rojo PT, Pereira RMR, Shinjo SK, Andrade DCO, Sampaio-Barros PD, Ribeiro CT, Deveza GBH, Martins VAO, Silva CA, Lopes MH, Duarte AJS, Antonangelo L, Sabino EC, Kallas EG, Pasoto SG, Bonfa E (2021) Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial. Nat Med 27(10):1744\u20131751. https:\/\/doi.org\/10.1038\/s41591-021-01469-5 (PMID: 34331051)","journal-title":"Nat Med"},{"issue":"10","key":"5119_CR19","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","volume":"80","author":"V Furer","year":"2021","unstructured":"Furer V, Eviatar T, Zisman D, Peleg H, Paran D, Levartovsky D, Zisapel M, Elalouf O, Kaufman I, Meidan R, Broyde A, Polachek A, Wollman J, Litinsky I, Meridor K, Nochomovitz H, Silberman A, Rosenberg D, Feld J, Haddad A, Gazzit T, Elias M, Higazi N, Kharouf F, Shefer G, Sharon O, Pel S, Nevo S, Elkayam O (2021) Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis 80(10):1330\u20131338. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220647 (PMID:34127481; PMCID:PMC8206170)","journal-title":"Ann Rheum Dis"},{"key":"5119_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-05017-9","author":"JA Esquivel-Valerio","year":"2021","unstructured":"Esquivel-Valerio JA, Skinner-Taylor CM, Moreno-Arquieta IA, Cardenas-de la Garza JA, Garcia-Arellano G, Gonzalez-Garcia PL, Almaraz-Juarez FDR, Galarza-Delgado DA (2021) Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-021-05017-9 (Epub ahead of print, PMID: 34622311; PMCID: PMC8496432)","journal-title":"Rheumatol Int"},{"issue":"8","key":"5119_CR21","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00296-021-04917-0","volume":"41","author":"S Cherian","year":"2021","unstructured":"Cherian S, Paul A, Ahmed S, Alias B, Manoj M, Santhosh AK, Varghese DR, Krishnan N, Shenoy P (2021) Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey. Rheumatol Int 41(8):1441\u20131445. https:\/\/doi.org\/10.1007\/s00296-021-04917-0 (Epub 2021 Jun 17, PMID: 34142203; PMCID: PMC8211311)","journal-title":"Rheumatol Int"},{"issue":"8","key":"5119_CR22","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1016\/S2665-9913(21)00181-8","volume":"3","author":"L Boekel","year":"2021","unstructured":"Boekel L, Kummer LY, van Dam KPJ, Hooijberg F, van Kempen Z, Vogelzang EH, Wieske L, Eftimov F, van Vollenhoven R, Kuijpers TW, van Ham SM, Tas SW, Killestein J, Boers M, Nurmohamed MT, Rispens T, Wolbink G (2021) Adverse events after first COVID-19 vaccination in patients with autoimmune diseases. Lancet Rheumatol 3(8):e542\u2013e545. https:\/\/doi.org\/10.1016\/S2665-9913(21)00181-8 (PMID:34179831; PMCID:PMC8213359)","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"5119_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13075-021-02674-w","volume":"24","author":"FR Spinelli","year":"2022","unstructured":"Spinelli FR, Favalli EG, Garufi C, Cornalba M, Colafrancesco S, Conti F, Caporali R (2022) Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine. Arthritis Res Ther 24(1):21. https:\/\/doi.org\/10.1186\/s13075-021-02674-w (PMID:35016701; PMCID:PMC8748531)","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"5119_CR24","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00296-021-04972-7","volume":"41","author":"LE Bartels","year":"2021","unstructured":"Bartels LE, Ammitzb\u00f8ll C, Andersen JB, Vils SR, Mistegaard CE, Johannsen AD, Hermansen MF, Thomsen MK, Erikstrup C, Hauge EM, Troldborg A (2021) Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int 41(11):1925\u20131931. https:\/\/doi.org\/10.1007\/s00296-021-04972-7 (PMID:34476603; PMCID:PMC8412379)","journal-title":"Rheumatol Int"},{"key":"5119_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05980-5","author":"E Zavala-Flores","year":"2021","unstructured":"Zavala-Flores E, Salcedo-Matienzo J, Quiroz-Alva A, Berrocal-Kasay A (2021) Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-021-05980-5 (Epub ahead of print, PMID: 34782941; PMCID: PMC8592807)","journal-title":"Clin Rheumatol"},{"key":"5119_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-05052-6","author":"YH Jeon","year":"2021","unstructured":"Jeon YH, Lim DH, Choi SW, Choi SJ (2021) A flare of Still\u2019s disease following COVID-19 vaccination in a 34-year-old patient. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-021-05052-6 (Epub ahead of print, PMID: 34797392; PMCID: PMC8602986)","journal-title":"Rheumatol Int"},{"key":"5119_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107970","volume":"99","author":"Y Ishay","year":"2021","unstructured":"Ishay Y, Kenig A, Tsemach-Toren T, Amer R, Rubin L, Hershkovitz Y, Kharouf F (2021) Autoimmune phenomena following SARS-CoV-2 vaccination. Int Immunopharmacol 99:107970. https:\/\/doi.org\/10.1016\/j.intimp.2021.107970 (PMID:34280851; PMCID:PMC8270741)","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"5119_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1053\/j.ajkd.2021.06.016","volume":"78","author":"MT Shakoor","year":"2021","unstructured":"Shakoor MT, Birkenbach MP, Lynch M (2021) ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis 78(4):611\u2013613. https:\/\/doi.org\/10.1053\/j.ajkd.2021.06.016 (PMID:34280507; PMCID:PMC8285210)","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"5119_CR29","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/vaccines9050435","volume":"9","author":"A Watad","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, Druyan A, Eltity M, Hijazi N, Haddad A, Elias M, Zisman D, Naffaa ME, Brodavka M, Cohen Y, Abu-Much A, Abu Elhija M, Bridgewood C, Langevitz P, McLorinan J, Bragazzi NL, Marzo-Ortega H, Lidar M, Calabrese C, Calabrese L, Vital E, Shoenfeld Y, Amital H, McGonagle D (2021) Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel) 9(5):435. https:\/\/doi.org\/10.3390\/vaccines9050435 (PMID:33946748; PMCID:PMC8146571)","journal-title":"Vaccines (Basel)"},{"issue":"24","key":"5119_CR30","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.3390\/jcm10245960","volume":"10","author":"E Bolletta","year":"2021","unstructured":"Bolletta E, Iannetta D, Mastrofilippo V, De Simone L, Gozzi F, Croci S, Bonacini M, Belloni L, Zerbini A, Adani C, Fontana L, Salvarani C, Cimino L (2021) Uveitis and other ocular complications following COVID-19 vaccination. J Clin Med 10(24):5960. https:\/\/doi.org\/10.3390\/jcm10245960 (PMID:34945256; PMCID:PMC8704915)","journal-title":"J Clin Med"},{"key":"5119_CR31","unstructured":"https:\/\/vaccine-safety-training.org\/classification-of-aefis.html Accessed 8 Mar 2022"},{"issue":"7","key":"5119_CR32","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/art.41734","volume":"73","author":"JR Curtis","year":"2021","unstructured":"Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, Calabrese C, Gravallese EM, Harpaz R, Sadun RE, Turner AS, Williams EA, Mikuls TR (2021) American College of Rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 1. Arthritis Rheumatol 73(7):1093\u20131107. https:\/\/doi.org\/10.1002\/art.41734 (Epub 2021 May 24, PMID: 33728796; PMCID: PMC8250724)","journal-title":"Arthritis Rheumatol"},{"key":"5119_CR33","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"issue":"10","key":"5119_CR34","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/art.1780401023","volume":"40","author":"A Livneh","year":"1997","unstructured":"Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879\u20131885. https:\/\/doi.org\/10.1002\/art.1780401023 (PMID: 9336425)","journal-title":"Arthritis Rheum"},{"key":"5119_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab751","author":"F Tagini","year":"2021","unstructured":"Tagini F, Carrel L, Fallet B, Gachoud D, Ribi C, Monti M (2021) Beh\u00e7et\u2019s-like adverse event or inaugural Beh\u00e7et\u2019s disease after SARS-CoV-2 mRNA-1273 vaccination? Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keab751 (Epub ahead of print, PMID: 34617989; PMCID: PMC8522430)","journal-title":"Rheumatology (Oxford)"},{"key":"5119_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17859","author":"H Hashizume","year":"2021","unstructured":"Hashizume H, Ajima S, Ishikawa Y (2021) Emergence of Beh\u00e7et\u2019s disease post-SARS-CoV2-vaccination: two clinical cases in Japan. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.17859 (Epub ahead of print, PMID: 34897826)","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"5119_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.713052","volume":"8","author":"I Mattioli","year":"2021","unstructured":"Mattioli I, Bettiol A, Saruhan-Direskeneli G, Direskeneli H, Emmi G (2021) Pathogenesis of Beh\u00e7et\u2019s syndrome: genetic, environmental and immunological factors. Front Med (Lausanne) 8(8):713052. https:\/\/doi.org\/10.3389\/fmed.2021.713052 (PMID:34692721; PMCID:PMC8531401)","journal-title":"Front Med (Lausanne)"},{"key":"5119_CR38","unstructured":"The Behcet\u2019s Disease Research Committee of Japan (1989) Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Beh\u00e7et\u2019s disease\u2014a multicenter study. J Rheumatol 16(4):506\u2013511 (PMID: 2664172)"},{"issue":"6","key":"5119_CR39","first-page":"1029","volume":"15","author":"Y Mizushima","year":"1988","unstructured":"Mizushima Y, Matsuda T, Hoshi K, Ohno S (1988) Induction of Beh\u00e7et\u2019s disease symptoms after dental treatment and streptococcal antigen skin test. J Rheumatol 15(6):1029\u20131030 (PMID: 3418627)","journal-title":"J Rheumatol"},{"issue":"4","key":"5119_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/0036933018801215","volume":"63","author":"M Saeidinejad","year":"2018","unstructured":"Saeidinejad M, Kardash S, Connell L (2018) Behcet\u2019s disease and severe inflammatory reaction to 23-valent pneumococcal polysaccharide vaccine: a case report and review of literature. Scott Med J 63(4):119\u2013121. https:\/\/doi.org\/10.1177\/0036933018801215 (PMID: 30253703)","journal-title":"Scott Med J"},{"issue":"4","key":"5119_CR41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/rheumatology\/ker388","volume":"51","author":"T H\u00fcgle","year":"2012","unstructured":"H\u00fcgle T, Bircher A, Walker UA (2012) Streptococcal hypersensitivity reloaded: severe inflammatory syndrome in Behcet\u2019s disease following 23-valent polysaccharide Streptococcus pneumoniae vaccine. Rheumatology (Oxford) 51(4):761\u2013762. https:\/\/doi.org\/10.1093\/rheumatology\/ker388 (PMID: 22157598)","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5119_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00296-021-05056-2","volume":"42","author":"G Ozcifci","year":"2022","unstructured":"Ozcifci G, Aydin T, Atli Z, Balkan II, Tabak F, Oztas M, Ozguler Y, Ugurlu S, Hatemi G, Melikoglu M, Fresko I, Hamuryudan V, Seyahi E (2022) The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Beh\u00e7et\u2019s syndrome. Rheumatol Int 42(1):101\u2013113. https:\/\/doi.org\/10.1007\/s00296-021-05056-2 (PMID:34825278; PMCID:PMC8614218)","journal-title":"Rheumatol Int"},{"key":"5119_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14279","author":"F Haslak","year":"2022","unstructured":"Haslak F, Gunalp A, Cebi MN, Yildiz M, Adrovic A, Sahin S, Barut K, Kasapcopur O (2022) Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: a single-center study. Int J Rheum Dis. https:\/\/doi.org\/10.1111\/1756-185X.14279 (Epub ahead of print, PMID: 34978376)","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"5119_CR44","doi-asserted-by":"publisher","first-page":"rkab043","DOI":"10.1093\/rap\/rkab043","volume":"5","author":"CJ Peet","year":"2021","unstructured":"Peet CJ, Papadopoulou C, Sombrito BRM, Wood MR, Lachmann HJ (2021) COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics. Rheumatol Adv Pract 5(2):rkab043. https:\/\/doi.org\/10.1093\/rap\/rkab043 (PMID: 34466775; PMCID: PMC8397842)","journal-title":"Rheumatol Adv Pract"},{"issue":"12","key":"5119_CR45","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1111\/jdv.15776","volume":"33","author":"M Reverte","year":"2019","unstructured":"Reverte M, Etienne M, Fouchard M, Doucet L, Brenaut E, Misery L (2019) Occurrence of Henoch\u2013Sch\u00f6nlein purpura in a patient treated with secukinumab. J Eur Acad Dermatol Venereol 33(12):e455\u2013e457. https:\/\/doi.org\/10.1111\/jdv.15776 (Epub 2019 Jul 16 PMID: 31282012)","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"5119_CR46","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","volume":"140","author":"DL Kastner","year":"2010","unstructured":"Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140(6):784\u2013790. https:\/\/doi.org\/10.1016\/j.cell.2010.03.002 (PMID:20303869; PMCID:PMC3541025)","journal-title":"Cell"},{"issue":"14","key":"5119_CR47","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jama.2021.15072","volume":"326","author":"NP Klein","year":"2021","unstructured":"Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE, Donahue JG, Kharbanda EO, Naleway A, Nelson JC, Xu S, Yih WK, Glanz JM, Williams JTB, Hambidge SJ, Lewin BJ, Shimabukuro TT, DeStefano F, Weintraub ES (2021) Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA 326(14):1390\u20131399. https:\/\/doi.org\/10.1001\/jama.2021.15072 (PMID:34477808; PMCID:PMC8511971)","journal-title":"JAMA"},{"issue":"12","key":"5119_CR48","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.3201\/eid2712.211634","volume":"27","author":"SC Shao","year":"2021","unstructured":"Shao SC, Wang CH, Chang KC, Hung MJ, Chen HY, Liao SC (2021) Guillain\u2013Barr\u00e9 syndrome associated with COVID-19 vaccination. Emerg Infect Dis 27(12):3175\u20133178. https:\/\/doi.org\/10.3201\/eid2712.211634 (PMID:34648420; PMCID:PMC8632191)","journal-title":"Emerg Infect Dis"},{"key":"5119_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100236","volume":"11","author":"R Shibli","year":"2021","unstructured":"Shibli R, Barnett O, Abu-Full Z, Gronich N, Najjar-Debbiny R, Doweck I, Rennert G, Saliba W (2021) Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell\u2019s palsy: a population-based study. Lancet Reg Health Eur 11:100236. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100236 (PMID:34751262; PMCID:PMC8566165)","journal-title":"Lancet Reg Health Eur"},{"issue":"10300","key":"5119_CR50","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0140-6736(21)00896-5","volume":"398","author":"I Katsoularis","year":"2021","unstructured":"Katsoularis I, Fonseca-Rodr\u00edguez O, Farrington P, Lindmark K, Fors Connolly AM (2021) Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet 398(10300):599\u2013607. https:\/\/doi.org\/10.1016\/S0140-6736(21)00896-5 (Epub 2021 Jul 29. PMID: 34332652; PMCID: PMC8321431)","journal-title":"Lancet"},{"issue":"12","key":"5119_CR51","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, Hern\u00e1n MA, Lipsitch M, Kohane I, Netzer D, Reis BY, Balicer RD (2021) Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med 385(12):1078\u20131090. https:\/\/doi.org\/10.1056\/NEJMoa2110475 (Epub 2021 Aug 25, PMID: 34432976; PMCID: PMC8427535)","journal-title":"N Engl J Med"},{"issue":"1","key":"5119_CR52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s10194-021-01311-w","volume":"22","author":"W Rattanawong","year":"2021","unstructured":"Rattanawong W, Akaratanawat W, Tepmongkol S, Chutinet A, Tantivatana J, Suwanwela NC (2021) Acute prolonged motor aura resembling ischemic stroke after COVID - 19 vaccination (CoronaVac): the first case report. J Headache Pain 22(1):93. https:\/\/doi.org\/10.1186\/s10194-021-01311-w (PMID:34384351; PMCID:PMC8358547)","journal-title":"J Headache Pain"},{"issue":"19","key":"5119_CR53","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.vaccine.2021.03.016","volume":"39","author":"SB Black","year":"2021","unstructured":"Black SB, Law B, Chen RT, Dekker CL, Sturkenboom M, Huang WT, Gurwith M, Poland G (2021) The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety. Vaccine 39(19):2712\u20132718. https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.016 (PMID:33846042; PMCID:PMC7936550)","journal-title":"Vaccine"},{"issue":"10295","key":"5119_CR54","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(21)01420-3","volume":"398","author":"AM Borobia","year":"2021","unstructured":"Borobia AM, Carcas AJ, P\u00e9rez-Olmeda M, Casta\u00f1o L, Bertran MJ, Garc\u00eda-P\u00e9rez J, Campins M, Portol\u00e9s A, Gonz\u00e1lez-P\u00e9rez M, Garc\u00eda Morales MT, Arana-Arri E, Aldea M, D\u00edez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Bar\u00f3n-Mira LE, Agust\u00ed A, P\u00e9rez-Ingidua C, G\u00f3mez de la C\u00e1mara A, Arribas JR, Ochando J, Alcam\u00ed J, Belda-Iniesta C, Fr\u00edas J (2021) Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet 398(10295):121\u2013130. https:\/\/doi.org\/10.1016\/S0140-6736(21)01420-3 (PMID: 34181880; PMCID: PMC8233007)","journal-title":"Lancet"},{"issue":"7","key":"5119_CR55","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, Sudre CH, Nguyen LH, Drew DA, Merino J, Hu C, Selvachandran S, Antonelli M, Murray B, Canas LS, Molteni E, Graham MS, Modat M, Joshi AD, Mangino M, Hammers A, Goodman AL, Chan AT, Wolf J, Steves CJ, Valdes AM, Ourselin S, Spector TD (2021) Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis 21(7):939\u2013949. https:\/\/doi.org\/10.1016\/S1473-3099(21)00224-3 (Epub 2021 Apr 27. PMID: 33930320; PMCID: PMC8078878)","journal-title":"Lancet Infect Dis"},{"key":"5119_CR56","doi-asserted-by":"publisher","first-page":"108860","DOI":"10.1016\/j.clim.2021.10886072","volume":"232","author":"S Shapiro Ben David","year":"2021","unstructured":"Shapiro Ben David S, Shamir-Stein N, BaruchGez S, Lerner U, Rahamim-Cohen D, Ekka Zohar A (2021) Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors\u2014a nationwide survey. Clin Immunol 232:108860. https:\/\/doi.org\/10.1016\/j.clim.2021.10886072 (Epub 2021 Sep 24, PMID: 34571262; PMCID: PMC8461972)","journal-title":"Clin Immunol"},{"issue":"1","key":"5119_CR57","doi-asserted-by":"publisher","first-page":"22777","DOI":"10.1038\/s41598-021-02321-z","volume":"11","author":"V Rotshild","year":"2021","unstructured":"Rotshild V, Hirsh-Raccah B, Miskin I, Muszkat M, Matok I (2021) Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis. Sci Rep 11(1):22777. https:\/\/doi.org\/10.1038\/s41598-021-02321-z (PMID:34815503; PMCID:PMC8611039)","journal-title":"Sci Rep"},{"issue":"8","key":"5119_CR58","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00296-020-04626-0","volume":"40","author":"E Seyahi","year":"2020","unstructured":"Seyahi E, Poyraz BC, Sut N, Akdogan S, Hamuryudan V (2020) The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey. Rheumatol Int 40(8):1229\u20131238. https:\/\/doi.org\/10.1007\/s00296-020-04626-0 (PMID:32572609;PMCID:PMC7306572)","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05119-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05119-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05119-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T07:03:34Z","timestamp":1653203014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05119-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5119"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05119-y","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,4]]},"assertion":[{"value":"21 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ayse Ozdede, Sabriye Guner, Guzin Ozcifci, Berna Yurttas, Zeynep Toker Dincer, Zeynep Atli, Ugur Uygunoglu, Eser Durmaz, Didar Ucar, Sabahattin Saip, and Vedat Hamuryudan declare that they have no conflict of interest. Serdal Ugurlu has received honoraria, consulting or speaker fees from Novartis, Pfizer, Lilly and Celltrion. Fehmi Tabak, has received honoraria, consulting or speaker fees from GSK, MSD, AbbVie and Gilead. Emire Seyahi has received honoraria, consulting or speaker fees from Novartis, Pfizer, AbbVie and Gilead.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}